Stomach Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are over 18 years old
• People whose cancer treatment is being given with the goal of curing or removing the cancer completely
• People who are planning to have regular check-ups to monitor for cancer coming back, as part of their normal care at the enrolling hospital or clinic
• People who are willing to sign a consent form agreeing to take part in the study
• People who agree to have their de-identified (anonymous) health information shared with the research team at regular intervals as described in the study
• People who are willing to provide blood samples when they join the study and at later check-up appointments, for up to 5 years
• People who have provided at least one key blood sample called a "Landmark" sample
• People who have a cancer confirmed by tissue testing that falls into one of the following groups:
  • Muscle-invasive cancer of the bladder, ureter, or the tube connecting the kidney to the bladder (stage II–III)
  • Non-small cell lung cancer (stage IB–III), either operable or inoperable
  • Invasive breast cancer where hormone receptor status and HER2 status are known, and the cancer is classified as high-risk HER2-positive, high-risk triple negative, or high-risk hormone receptor-positive/HER2-negative breast cancer
  • Skin melanoma at stage IIB–III, or a limited, surgically removable stage IV melanoma treated with curative intent
  • Cancer of the oesophagus or the junction between the oesophagus and stomach (stage II–III)
  • Stomach (gastric) cancer (stage II–III)
  • Pancreatic cancer that has been surgically removed or is eligible for surgical removal
  • Invasive squamous cell cancer of the head and neck, including cancers of the mouth, throat, voice box, and nearby areas (stage I–IVB)
  • High-risk ovarian or fallopian tube cancer (specific staging and tissue type criteria apply — confirm with trial site)
  • High-risk uterine (endometrial) cancer (2023 staging criteria stage II–III)
  • High-risk kidney (renal cell) cancer, including certain surgically removable stage IV cases treated with curative intent
  • Confirmed rectal cancer located in the lower part of the bowel that is undergoing or has undergone pre-surgery chemotherapy or immunotherapy treatment (exploratory group)

Who may not be able to join:

• People who have previously received an organ or tissue transplant from another person
• People whose cancer is primarily of a type called neuroendocrine (a specific tissue type — confirm with trial site)
• People who have been diagnosed with another separate primary cancer within the 3 years before enrolling, with some exceptions — certain low-risk or early-stage cancers such as in situ cancers, non-melanoma skin cancers, low- or intermediate-risk prostate cancer, early thyroid cancer, and some cases of cancer in both sides of the same organ may still be eligible (confirm with trial site)
• People whose cancer has spread to distant parts of the body at the time of joining, except for those with limited, surgically removable stage IV melanoma or kidney cancer

Important: Always verify eligibility with the trial site directly before applying.